Skip to main content
Premium Trial:

Request an Annual Quote

Jonathan Zhao, Lei Li, Min Wang

Veritas Genetics has named the leaders of its Asian R&D center established in Hangzhou, China. Veritas Co-founder Jonathan Zhao is the managing director, Lei Li is the vice president of global clinical and regulatory affairs, and Min Wang is the vice president of China R&D. 

Zhao has more than 15 years of Asia strategy and product launch experience with Amgen and Pfizer. Li was recently the leader of the clinical genetics laboratory at Novartis in Boston, and previous to that held a similar position at Pfizer. Wang joins Veritas from the Human Genome Sequencing Center of the Baylor College of Medicine.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.